Published in J Med Virol on November 01, 1991
Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest (1997) 2.10
Enhanced virulence, airway inflammation and impaired lung function induced by respiratory syncytial virus deficient in secreted G protein. Thorax (2004) 0.90
Assessment of signs of influenza illness in the ferret model. J Virol Methods (1989) 3.07
Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis (1989) 2.21
Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis (2000) 2.08
Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis (1986) 1.68
Encephalitis associated with erythema infectiosum. J Pediatr (1970) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49
Transmission of rubella from newborns. A controlled study among young adult women and report of an unusual case. Am J Dis Child (1965) 1.39
Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis (1990) 1.32
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Reye's syndrome: epidemiologic and viral studies, 1963-1974. Am J Epidemiol (1975) 1.28
A study of erythema infectiosum: recovery of rubella virus and echovirus-12. Pediatrics (1972) 1.27
Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis (1991) 1.23
A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol (1972) 1.21
Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol (1990) 1.20
Association of Reye's syndrome with viral infection. Lancet (1974) 1.17
Genetics of surface antigen expression in Pneumocystis carinii. Infect Immun (2001) 1.15
Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13
Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. Vaccine (1998) 1.12
Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis (1991) 1.11
Rubella-vaccinated students. Follow-up in a public school system. JAMA (1978) 1.10
Measles IgM response during reinfection of previously vaccinated children. J Pediatr (1973) 1.10
Rubella vaccine evaluation in a public school system. Am J Dis Child (1969) 1.09
Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope. Proc Natl Acad Sci U S A (1992) 1.05
Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis (1978) 1.05
Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. Antiviral Res (1989) 1.04
Local and systemic antibody response to rotavirus WC3 vaccine in adult volunteers. Antiviral Res (1989) 1.02
Measles antibody in previously immunized children. The need for revaccination. Am J Dis Child (1972) 1.02
Screening hospital patients for hepatitis B surface antigen. Am J Clin Pathol (1977) 1.01
Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. J Virol (1990) 0.98
Studies on congenital rubella. Preliminary results on the frequency and significance of presence of rubella virus in the newborn and the effect of gamma-globulin in preventing congenital rubella. Am J Dis Child (1965) 0.98
Rubella: recent laboratory and clinical advances. Prog Med Virol (1966) 0.98
Rubella antibody levels in juvenile rheumatoid arthritis. Ann Rheum Dis (1975) 0.97
Protection of adults rechallenged with a human rotavirus. J Infect Dis (1990) 0.97
Fatal viral encephalitis in children with X-linked hypogammaglobulinemia. Am J Dis Child (1973) 0.96
Clinical evaluation of a new measles-mumps-rubella trivalent vaccine. Am J Dis Child (1975) 0.96
Experimental rubella studies. I. Clinical and laboratory features of infection caused by the Brown strain rubella virus. II. Artificial challenge studies of adult rubella vaccinees. Am J Dis Child (1969) 0.95
Rubella: studies on the natural disease. The significance of antibody status and communicability among young women. Am J Dis Child (1965) 0.94
Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody. J Infect Dis (1992) 0.94
Effect of vaccination on serotype-specific antibody responses in infants administered WC3 bovine rotavirus before or after a natural rotavirus infection. J Infect Dis (1990) 0.93
Cell-mediated immunity in humans during viral infection: dermal hypersensitivity and in vitro lymphocyte proliferation during mild viral respiratory infections. Infect Immun (1974) 0.91
Prevention of surface-to-human transmission of rotaviruses by treatment with disinfectant spray. J Clin Microbiol (1991) 0.91
Culture adaptation and characterization of group A rotaviruses causing diarrheal illnesses in Bangladesh from 1985 to 1986. J Clin Microbiol (1991) 0.90
Expression and complexity of the PRT1 multigene family of Pneumocystis carinii. Microbiology (2004) 0.89
Time between inoculations and karyotype forms of Pneumocystis carinii f. sp. Carinii influence outcome of experimental coinfections in rats. Infect Immun (2001) 0.89
Experimental rubella. Clinical and laboratory findings. Arch Intern Med (1965) 0.89
Influenza in ferrets and guinea pigs: effect on cell-mediated immunity. Infect Immun (1978) 0.88
Induction and persistence of local rotavirus antibodies in relation to serum antibodies. J Med Virol (1989) 0.87
A human volunteer challenge model using frozen bacteria of the new epidemic serotype, V. cholerae O139 in Thai volunteers. Vaccine (2001) 0.86
Challenge with rubella virus after loss of detectable vaccine-induced antibody. Rev Infect Dis (1985) 0.86
Evaluation of a live, attenuated recombinant influenza vaccine in high school children. Infect Immun (1975) 0.85
Late onset of fatal cytomegalovirus infection after renal transplantation. Primary or reactivation infection? Arch Intern Med (1978) 0.85
Titered lots of immune globulin (Ig). Efficacy in the prevention of rubella. Am J Dis Child (1969) 0.85
Similar subclass antibody responses after intranasal immunization with UV-inactivated RSV mixed with cholera toxin or live RSV. J Med Virol (1991) 0.85
Experimental rubella in pregnant rhesus monkeys. J Infect Dis (1966) 0.83
Detection of viremia by a one step polymerase chain reaction method in hepatitis C virus infection. Virus Res (1993) 0.82
Rubella control. Am J Dis Child (1971) 0.82
Rapid recovery in mice after combined nasal/oral immunization with killed respiratory syncytial virus. J Med Virol (1990) 0.82
Studies of echovirus-12 in volunteers: determination of minimal infectious dose and the effect of previous infection on infectious dose. J Infect Dis (1984) 0.82
Herpesvirus hominis type 2 meningoencephalitis following renal transplantation. Am J Med (1976) 0.82
Rubella vaccinees in a public school system: a four and one-half-year follow-up. Am J Dis Child (1974) 0.82
Salivary antibody titers in adults challenged with a human rotavirus. J Med Virol (1992) 0.81
Reye's syndrome. Annu Rev Med (1976) 0.81
Oral ribavirin treatment of influenza A and B. Antimicrob Agents Chemother (1987) 0.80
Influenza-specific ELISA IgA and IgG predict severity of influenza disease in subjects prescreened with hemagglutination inhibition. Antiviral Res (1990) 0.80
Salicylate intoxication and influenza in ferrets. Pediatr Res (1979) 0.80
Genetic and antigenic variation in Pneumocystis carinii organisms: tools for examining the epidemiology and pathogenesis of infection. J Lab Clin Med (1997) 0.80
The use of genetic markers to characterize transmission of Pneumocystis carinii. AIDS Patient Care STDS (1997) 0.79
Rocky Mountain spotted fever in Clermont County, Ohio: description of an endemic focus. Am J Epidemiol (1973) 0.79
Follow-up studies of rubella vaccinees at adolescence. J Pediatr (1975) 0.78
The minimum number of Pneumocystis carinii f. sp. carinii organisms required to establish infections is very low. J Eukaryot Microbiol (1999) 0.78
Two-year follow-up of rubella vaccinees in a public school system. Am J Dis Child (1972) 0.78
Development and evaluation of an off-the-slide genotyping technique for identifying Giardia cysts and Cryptosporidium oocysts directly from US EPA Method 1623 slides. J Appl Microbiol (2013) 0.77
Febrile illness in early infancy associated with ECHO virus infection. J Pediatr (1974) 0.77
Isolation and characterization of mouse nasal lymphocytes. J Immunol Methods (1989) 0.77
Ribavirin small-particle-aerosol treatment of influenza B virus infection. Antimicrob Agents Chemother (1988) 0.76
Identification of porcine Pneumocystis carinii as a genetically distinct organism by DNA amplification. APMIS (1997) 0.76
Serological survey for rubella and measles antibodies among first graders. JAMA (1974) 0.75
Stability of the rabbit immunogenic marker of RA 27-3 rubella vaccine virus after human passage. Infect Immun (1974) 0.75
A design for the evaluation of antiviral drugs in human influenza. Am J Epidemiol (1970) 0.75
Misinformation about Pneumocystis. Clin Exp Dermatol (2009) 0.75
Poliovirus antibody in urban school children. J Pediatr (1974) 0.75
Rubella surveillance and immunization among adolescent girls in Cincinnati. Am J Dis Child (1972) 0.75
Letter: Post-transfusion viral infections in Reye syndrome. J Pediatr (1976) 0.75
Proceedings: Rubella surveillance and vaccination at adolescence. Acta Paediatr Scand Suppl (1975) 0.75
Evaluation of a trivalent measles, mumps, rubella vaccine in children. J Pediatr (1975) 0.75
Genital viral surveillance among sexually active adolescent girls. J Pediatr (1977) 0.75
Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age. Pediatr Infect Dis J (1993) 0.75
Wither we goest? Notes of a society watcher plus other comments and thoughts. J Lab Clin Med (1986) 0.75
Differential effect of amantadine hydrochloride on the systemic and local immune response to influenza A. J Med Virol (1989) 0.75
Evaluation of RA 27-3 rubella vaccine. J Pediatr (1974) 0.75
Rubella and measles serosurvey among a nonurban pediatric population. Am J Dis Child (1975) 0.75
Rubella surveillance and immunization among college women. Obstet Gynecol (1974) 0.75
Staphylococcus aureus endocarditis. J Lab Clin Med (1971) 0.75